$NVFY
Nova Lifestyle, Inc. Stock $nvfy

$nvfy Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000149315223017318 Filed on May 15, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022 Q1
Revenue	$1.875M	$2.250M	$3.666M
YoY Change	-48.87%	-25.38%	10.09%
Cost Of Revenue	$1.213M	$1.414M	$2.138M
YoY Change	-43.24%	-88.32%	9.62%
Gross Profit	$661.3K	$835.8K	$1.528M
YoY Change	-56.73%	-109.19%	10.75%
Gross Profit Margin	35.28%	37.15%	41.69%
Selling, General & Admin	$1.845M	$1.857M	$2.348M
YoY Change	-21.43%	-26.13%	9.72%
% of Gross Profit	278.98%	222.19%	153.64%
Research & Development	$118.00	$590.00	$8.660K
YoY Change	-98.64%	1375.0%
% of Gross Profit	0.02%	0.07%	0.57%
Depreciation & Amortization	$18.42K	$26.18K	$21.86K
YoY Change	-15.75%	12.65%	9.3%
% of Gross Profit	2.79%	3.13%	1.43%
Operating Expenses	$1.845M	$1.858M	$2.357M
YoY Change	-21.72%	-26.11%	9.62%
Operating Profit	-$1.184M	-$1.022M	-$828.4K
YoY Change	42.88%	-91.19%	7.59%
Interest Expense	-$40.43K	-$50.77K	-$33.08K
YoY Change	22.22%	-450.38%	-430.8%
% of Operating Profit
Other Income/Expense, Net	-$38.71K	$470.00	-$47.55K
YoY Change	-18.6%	-99.6%
Pretax Income	-$1.222M	-$8.771M	-$898.1K
YoY Change	36.11%	-23.55%	19.74%
Income Tax		$2.400K
% Of Pretax Income
Net Earnings	-$1.222M	-$8.799M	-$898.1K
YoY Change	36.11%	-23.2%	18.16%
Net Earnings / Revenue	-65.21%	-391.11%	-24.5%
Basic Earnings Per Share	-$0.17		-$0.13
Diluted Earnings Per Share	-$0.17	-$1.24	-$131.2K
COMMON SHARES
Basic Shares Outstanding	7.170M shares	6.950M shares	6.846M shares
Diluted Shares Outstanding	1.434M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$649.4K	$1.374M	$5.368M
YoY Change	-87.9%	-78.1%	-29.74%
Cash & Equivalents	$649.4K	$1.374M	$5.368M
Short-Term Investments
Other Short-Term Assets	$1.936M	$1.526M	$615.6K
YoY Change	214.57%	37.01%	36.8%
Inventory	$4.165M	$4.933M	$18.69M
Prepaid Expenses	$1.874M	$1.505M
Receivables	$262.6K	$288.5K	$289.5K
Other Receivables	$34.86K	$79.18K	$351.4K
Total Short-Term Assets	$7.049M	$8.200M	$25.32M
YoY Change	-72.16%	-67.93%	-39.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$349.4K	$368.6K	$3.417M
YoY Change	-89.78%	-27.82%	34.02%
Goodwill	$218.6K	$218.6K
YoY Change		0.0%
Intangibles	$12.50K	$13.84K
YoY Change		-27.96%
Long-Term Investments
YoY Change
Other Assets	$71.07K	$71.15K	$72.46K
YoY Change	-1.92%	-2.06%	-61.86%
Total Long-Term Assets	$3.118M	$3.333M	$3.708M
YoY Change	-15.92%	-15.84%	25.29%
TOTAL ASSETS
Total Short-Term Assets	$7.049M	$8.200M	$25.32M
Total Long-Term Assets	$3.118M	$3.333M	$3.708M
Total Assets	$10.17M	$11.53M	$29.03M
YoY Change	-64.97%	-60.94%	-35.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$416.2K	$321.3K	$681.9K
YoY Change	-38.96%	-10.35%	39.16%
Accrued Expenses	$1.033M	$1.064M	$1.221M
YoY Change	-15.45%	15.58%	32.75%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.641M	$1.643M	$2.288M
YoY Change	-28.3%	-9.46%	57.82%
LONG-TERM LIABILITIES
Long-Term Debt	$149.8K	$150.0K	$150.0K
YoY Change	-0.12%	0.0%	0.0%
Other Long-Term Liabilities	$2.944M	$3.129M	$3.945M
YoY Change	-25.36%	-24.07%	22.89%
Total Long-Term Liabilities	$3.094M	$3.279M	$4.095M
YoY Change	-24.43%	-23.23%	21.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.641M	$1.643M	$2.288M
Total Long-Term Liabilities	$3.094M	$3.279M	$4.095M
Total Liabilities	$4.735M	$4.922M	$6.383M
YoY Change	-25.82%	-19.12%	32.71%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.93M	-$36.71M
YoY Change		87.23%
Common Stock	$43.29M	$7.199K
YoY Change		-99.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.432M	$6.612M	$22.64M
YoY Change
Total Liabilities & Shareholders Equity	$10.17M	$11.53M	$29.03M
YoY Change	-64.97%	-60.94%	-35.15%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.222M	-$8.799M	-$898.1K
YoY Change	36.11%	-23.2%	18.16%
Depreciation, Depletion And Amortization	$18.42K	$26.18K	$21.86K
YoY Change	-15.75%	12.65%	9.3%
Cash From Operating Activities	-$732.4K	-$1.914M	-$856.6K
YoY Change	-14.5%	15.79%	-2.66%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$3.000K
YoY Change		782.35%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities		-$3.000K
YoY Change		-982.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-$732.4K	-1.914M	-856.6K
Cash From Investing Activities		-3.000K
Cash From Financing Activities		0.000
Net Change In Cash	-$724.8K	-1.917M	$0.00
YoY Change		16.0%
FREE CASH FLOW
Cash From Operating Activities	-$732.4K	-$1.914M	-$856.6K
Capital Expenditures	$0.00	$3.000K
Free Cash Flow	-$732.4K	-$1.917M
YoY Change		15.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001473334
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent		usd
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent		usd
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations		usd
CY2023Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
CY2022Q1	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations		usd
CY2023Q1	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
CY2022Q1	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	NVFY	Income Tax Payments Discontinued Operations IncomeTaxPaymentsDiscontinuedOperations		usd
CY2022Q1	NVFY	Income Tax Payments Discontinued Operations IncomeTaxPaymentsDiscontinuedOperations		usd
CY2023Q1	us-gaap	Interest Paid Discontinued Operations InterestPaidDiscontinuedOperations		usd
CY2022Q1	us-gaap	Interest Paid Discontinued Operations InterestPaidDiscontinuedOperations		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	34858	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	79175	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4932642	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1873600	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2022Q1	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue		usd
CY2022Q1	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold		usd
CY2022Q1	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent		usd
CY2023Q1	NVFY	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-36259
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	NOVA LIFESTYLE, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0746568
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	6565 E. Washington Blvd
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Commerce
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90040
CY2023Q1	dei	City Area Code CityAreaCode	323
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	888-9999
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	NVFY
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7238375	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	649400	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1374167	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	262641	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	288478	usd
CY2023Q1	NVFY	Advance To Suppliers AdvanceToSuppliers	62880	usd
CY2022Q4	NVFY	Advance To Suppliers AdvanceToSuppliers	21173	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	4165449	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1504671	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	7048828	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	8200306	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	349396	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	368624	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2466645	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2660977	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12496	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13837	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	71066	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	71146	usd
CY2023Q1	us-gaap	Goodwill Goodwill	218606	usd
CY2022Q4	us-gaap	Goodwill Goodwill	218606	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	3118209	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3333190	usd
CY2023Q1	us-gaap	Assets Assets	10167037	usd
CY2022Q4	us-gaap	Assets Assets	11533496	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	416184	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	321261	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	723732	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	736428	usd
CY2023Q1	NVFY	Advance From Customers Current AdvanceFromCustomersCurrent	185945	usd
CY2022Q4	NVFY	Advance From Customers Current AdvanceFromCustomersCurrent	170139	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	314230	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	413599	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	629	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	629	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	621	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1640720	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1642677	usd
CY2023Q1	us-gaap	Other Loans Payable OtherLoansPayable	149815	usd
CY2022Q4	us-gaap	Other Loans Payable OtherLoansPayable	150000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1786888	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1971386	usd
CY2023Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1157603	usd
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1157603	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3094306	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3278989	usd
CY2023Q1	us-gaap	Liabilities Liabilities	4735026	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4921666	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	15000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7245393	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7245393	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7119180	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7119180	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	7245	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7199	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	43279499	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	43233942	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	74135	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	77242	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37928868	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36706553	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5432011	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6611830	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10167037	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11533496	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1874565	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3665946	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1213263	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	2137618	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	661302	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1528328	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	714514	usd
CY2022Q1	us-gaap	Selling Expense SellingExpense	768333	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1130398	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1584738	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1844912	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2353071	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1183610	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-824743	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1719	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5383	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	17763	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1909	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-17567	usd
CY2023Q1	NVFY	Financial Expenses FinancialExpenses	33132	usd
CY2022Q1	NVFY	Financial Expenses FinancialExpenses	47746	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-38705	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-47550	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1222315	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-872293	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1222315	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-872293	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-25754	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1222315	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-898047	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3107	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-54873	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1225422	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-952920	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7170060	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6845683	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.17
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6611830	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	885	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	16000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	28718	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3107	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1222315	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5432011	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23444188	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23444188	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	3300	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	148032	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-54873	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-898047	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	22642600	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	22642600	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1222315	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-898047	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-25754	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1222315	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-872293	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19759	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20748	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	193941	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	189606	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	85672	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	46885	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	151332	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-261	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1880	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-26098	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	187957	usd
CY2023Q1	NVFY	Increase Decrease In Advance To Suppliers IncreaseDecreaseInAdvanceToSuppliers	41707	usd
CY2022Q1	NVFY	Increase Decrease In Advance To Suppliers IncreaseDecreaseInAdvanceToSuppliers	-439344	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-677033	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1036598	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	331233	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-125732	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-196838	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-186835	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	94923	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	323498	usd
CY2023Q1	NVFY	Increase Decrease In Advance From Customers IncreaseDecreaseInAdvanceFromCustomers	15806	usd
CY2022Q1	NVFY	Increase Decrease In Advance From Customers IncreaseDecreaseInAdvanceFromCustomers	-24953	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-100184	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	76468	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-732421	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-980028	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	123433	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-732421	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-856595	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7654	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-51501	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-724767	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-908096	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1374167	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6276106	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	649400	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5368010	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	197488	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1951	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	4048	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1222315	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zUAVSa4U3xQk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_86B_zKerseUnf578">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In preparing condensed consolidated financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the dates of the condensed consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made by management include, but are not limited to, revenue recognition, the allowance for bad debt, valuation of inventories, the valuation of stock-based compensation, income taxes and unrecognized tax benefits, valuation allowance for deferred tax assets, assumptions used in assessing impairment of long-lived assets and goodwill, and loss contingencies. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2914	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-261	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2653	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-261	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1880	usd
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	85672	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-872293	usd
CY2023Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	118	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8663	usd
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	25600000	usd
CY2022Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	25000000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	411575	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	298132	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-25754	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1222315	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-898047	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7170060	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.17
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Shares Period Increase Decrease SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease	14000	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Shares Period Increase Decrease SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease	36307	shares
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zSLvhqpxRdx5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_863_zSamO3cc7kw">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Financial instruments that potentially subject the Company to credit risk consist primarily of accounts and other receivables. The Company does not require collateral or other security to support these receivables. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">No customer accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zSeQwQSaebB5" title="Concentration risk percentage"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zlwagH5VpGSb" title="Concentration risk percentage">10</span></span>% or more of the Company’s sales from continuing operations for the three months ended March 31, 2023 and 2022. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No customer accounted for <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--StatementOperatingActivitiesSegmentAxis__us-gaap--SegmentDiscontinuedOperationsMember_zzSa6rs9QoN5" title="Concentration risk percentage">10</span>% of the Company’s sales from discontinued operations for the three months ended March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Company purchased its products from three and four major vendors during the three months ended March 31, 2023 and 2022, respectively, accounting for a total of <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeVendorsMember_zDsZ4Lg82EX7">68</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">% for 2023 (<span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember_zSOo6Q4rUdSl">35</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">%, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember_zV7unIxfvnmd">19</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">%, and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorThreeMember_zbGvOpv3fnna">14</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">%) and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourVendorsMember_zQpDCp0Cco11">69</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">% for 2022 (<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember_zEbwxRU3NPYb">26</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember_zD53uqMXBQtg">17</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">%, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorThreeMember_zf1ApBOxIHu6">14</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">%, and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorFourMember_zY5uexPwU5gj">12</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">%) of the Company’s purchases from continuing operations, respectively.<br/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances made to these vendors were $<span id="xdx_905_ecustom--AdvancesToSuppliers_iI_c20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zrZb3479F2vb" title="Advances made to suppliers"><span id="xdx_902_ecustom--AdvancesToSuppliers_iI_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zeNbJCx237bc" title="Advances made to suppliers">0</span></span> as of March 31, 2023 and December 31, 2022. Accounts payable to these vendors were $<span id="xdx_90E_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_pp0p0_c20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zI4FID1X5iz4" title="Accounts payable to suppliers">28,570</span> and $<span id="xdx_908_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zW002PxGwrR9" title="Accounts payable to suppliers">62,251</span> as of March 31, 2023 and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">No vendor accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoVendorMember_zBuCqMg3m8Wa" title="Concentration risk percentage">10</span>% of the Company’s purchases from discontinued operations for the three months ended March 31, 2022.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_843_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zZFnInPX044c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_865_zDBkUgd4EXre">Reclassification</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Certain prior period accounts have been reclassified in conformity with current period’s presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	3671	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-22083	usd
CY2022Q1	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-25754	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-25754	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	4165449	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4932642	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	85672	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	668076	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	669270	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	318680	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	300646	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	349396	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	368624	usd
CY2023Q1	us-gaap	Depreciation Depreciation	18418	usd
CY2022Q1	us-gaap	Depreciation Depreciation	20748	usd
CY2022Q1	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	1107	usd
CY2023Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	26800	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	26800	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14304	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12963	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12496	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13837	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1341	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1341	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	62880	usd
CY2022Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	21173	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1873600	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1504671	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	34858	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	79175	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1908458	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1583846	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	10000000
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	2110640	usd
CY2023Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	8000000
CY2023Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	1812826	usd
CY2023Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	5310	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	15225	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6612	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	6612	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	71415	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	20000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	85000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	23296	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	38349	usd
CY2023Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	56901	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	69592	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	202111	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	127406	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	314230	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	413599	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1225959	shares
CY2022Q4	NVFY	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	3.50
CY2023Q1	NVFY	Share Based Weighted Average Remaining Contractual Term Outstanding ShareBasedWeightedAverageRemainingContractualTermOutstanding	P4Y7D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1225959	shares
CY2023Q1	NVFY	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	3.50
CY2023Q1	NVFY	Share Based Weighted Average Remaining Contractual Term Outstanding1 ShareBasedWeightedAverageRemainingContractualTermOutstanding1	P3Y9M7D
CY2023Q1	NVFY	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable1	1225959	shares
CY2023Q1	NVFY	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice	3.50
CY2023Q1	NVFY	Share Based Weighted Average Remaining Contractual Term Exercisable ShareBasedWeightedAverageRemainingContractualTermExercisable	P3Y9M7D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	134000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.58
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P1Y3M29D
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	134000	shares
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	4.58
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P1Y3M29D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	134000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.58
CY2023Q1	NVFY	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm	P1Y29D
CY2023Q1	NVFY	Share Based Compensation Arrangement By Share Based Payment Awards Option Vested And Expected To Vest Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionVestedAndExpectedToVestExercisable	134000	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	4.58
CY2023Q1	NVFY	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm	P1Y29D
CY2023Q1	NVFY	Intrinsic Value Off Stock Options IntrinsicValueOffStockOptions	0.60
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1874565	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3665946	usd
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	2887107	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	3100747	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	219685	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	215542	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	600394	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	758237	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	701142	usd
CY2023Q1	NVFY	Lessee Operating Lease Liability Payments Due After Year Two LesseeOperatingLeaseLiabilityPaymentsDueAfterYearTwo	598820	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2658593	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	147973	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2510620	usd
CY2023Q1	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	215193	usd
CY2022Q1	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	212771	usd
CY2018Q4	us-gaap	Loss Contingency Allegations LossContingencyAllegations	On December 28, 2018, a federal putative class action complaint was filed by George Barney against the Company and its former and current CEOs and CFOs (Thanh H. Lam, Ya Ming Wong, Jeffery Chuang and Yuen Ching Ho) in the United States District Court for the Central District of California, claiming the Company violated federal securities laws and pursuing remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 (the “Barney Action”). Richard Deutner and ITENT EDV were subsequently appointed as lead plaintiffs and, on June 18, 2019, filed an Amended Complaint.
CY2018Q4	us-gaap	Loss Contingency Actions Taken By Plaintiff LossContingencyActionsTakenByPlaintiff	Plaintiffs seek to represent a class of entities acquiring Nova’s stock from December 3, 2015 through December 20, 2018. They claim that during this period the Company: (1) overstated its purported strategic alliance with a customer in China to operate as lead designer and manufacturer for all furnishings in its planned $460 million senior care center in China; and (2) inflated sales in 2016 and 2017 by recognizing significant sales to two allegedly non-existent customers.
CY2022Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	750000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-23-017318-index-headers.html	Edgar Link	pending
0001493152-23-017318-index.html	Edgar Link	pending
0001493152-23-017318.txt	Edgar Link	pending
0001493152-23-017318-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nvfy-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
nvfy-20230331_cal.xml	Edgar Link	unprocessable
nvfy-20230331_def.xml	Edgar Link	unprocessable
nvfy-20230331_lab.xml	Edgar Link	unprocessable
nvfy-20230331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVFY
Nova Lifestyle, Inc. Stock $nvfy

2023 Q1 Form 10-Q Financial Statement

#000149315223017318 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVFY Nova Lifestyle, Inc. Stock $nvfy

2023 Q1 Form 10-Q Financial Statement

#000149315223017318 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVFY
Nova Lifestyle, Inc. Stock $nvfy